Jonathan Woo Cunningham, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 29 | 2023 | 10900 | 2.570 |
Why?
|
| Stroke Volume | 20 | 2023 | 5007 | 1.750 |
Why?
|
| Natriuretic Peptide, Brain | 7 | 2023 | 1573 | 1.580 |
Why?
|
| Tetrazoles | 4 | 2022 | 835 | 1.510 |
Why?
|
| Ventricular Function, Left | 10 | 2023 | 3670 | 1.230 |
Why?
|
| Diuretics | 4 | 2023 | 592 | 1.020 |
Why?
|
| Natriuretic Peptides | 3 | 2023 | 150 | 0.910 |
Why?
|
| Biphenyl Compounds | 5 | 2022 | 913 | 0.880 |
Why?
|
| Peptide Fragments | 6 | 2023 | 5097 | 0.830 |
Why?
|
| Heterocyclic Compounds, 2-Ring | 1 | 2020 | 22 | 0.770 |
Why?
|
| Sodium | 2 | 2022 | 1623 | 0.620 |
Why?
|
| Troponin T | 2 | 2023 | 754 | 0.590 |
Why?
|
| Troponin I | 1 | 2021 | 619 | 0.580 |
Why?
|
| Spironolactone | 1 | 2020 | 382 | 0.570 |
Why?
|
| Amyloidosis | 1 | 2022 | 795 | 0.540 |
Why?
|
| Benzimidazoles | 1 | 2020 | 850 | 0.500 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 1912 | 0.470 |
Why?
|
| Renal Insufficiency | 1 | 2019 | 804 | 0.460 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1741 | 0.430 |
Why?
|
| Anti-Obesity Agents | 1 | 2014 | 217 | 0.390 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 1869 | 0.370 |
Why?
|
| Angiotensin Receptor Antagonists | 6 | 2022 | 924 | 0.370 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 15165 | 0.370 |
Why?
|
| Drug Combinations | 3 | 2020 | 1959 | 0.340 |
Why?
|
| Heart Diseases | 1 | 2021 | 2788 | 0.310 |
Why?
|
| Patient Selection | 1 | 2020 | 4215 | 0.310 |
Why?
|
| Length of Stay | 1 | 2019 | 6309 | 0.280 |
Why?
|
| Electronic Health Records | 1 | 2023 | 4468 | 0.270 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 6487 | 0.270 |
Why?
|
| Heart Defects, Congenital | 2 | 2022 | 4584 | 0.250 |
Why?
|
| Pulmonary Artery | 1 | 2013 | 1912 | 0.250 |
Why?
|
| Heart | 3 | 2023 | 4467 | 0.230 |
Why?
|
| Heart Transplantation | 1 | 2017 | 3110 | 0.230 |
Why?
|
| Heart Failure, Diastolic | 1 | 2023 | 69 | 0.220 |
Why?
|
| Humans | 41 | 2023 | 744343 | 0.220 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2023 | 176 | 0.210 |
Why?
|
| Hospitalization | 7 | 2023 | 10262 | 0.210 |
Why?
|
| Furosemide | 1 | 2022 | 167 | 0.210 |
Why?
|
| Double-Blind Method | 3 | 2020 | 12026 | 0.200 |
Why?
|
| Prognosis | 6 | 2023 | 29063 | 0.200 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 135 | 0.200 |
Why?
|
| Vasodilator Agents | 2 | 2023 | 977 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 2073 | 0.200 |
Why?
|
| Benzhydryl Compounds | 2 | 2023 | 845 | 0.180 |
Why?
|
| Embolism | 1 | 2022 | 408 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 11725 | 0.170 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 11727 | 0.160 |
Why?
|
| Glucosides | 1 | 2022 | 451 | 0.160 |
Why?
|
| Systole | 1 | 2020 | 958 | 0.150 |
Why?
|
| Amyloid | 1 | 2022 | 795 | 0.150 |
Why?
|
| Apolipoprotein E4 | 1 | 2021 | 668 | 0.150 |
Why?
|
| Neprilysin | 1 | 2020 | 439 | 0.150 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 451 | 0.150 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 12261 | 0.140 |
Why?
|
| Aged | 11 | 2023 | 163280 | 0.140 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 759 | 0.140 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 851 | 0.130 |
Why?
|
| Atherosclerosis | 2 | 2023 | 3445 | 0.130 |
Why?
|
| Protein Precursors | 1 | 2020 | 1154 | 0.130 |
Why?
|
| Risk Factors | 6 | 2022 | 72290 | 0.130 |
Why?
|
| Hospital Mortality | 4 | 2021 | 5317 | 0.130 |
Why?
|
| Hypoglycemia | 1 | 2022 | 861 | 0.130 |
Why?
|
| Natural Language Processing | 1 | 2023 | 1041 | 0.130 |
Why?
|
| Phentermine | 1 | 2014 | 33 | 0.120 |
Why?
|
| Male | 15 | 2023 | 350118 | 0.120 |
Why?
|
| Morbidity | 1 | 2020 | 1769 | 0.120 |
Why?
|
| Survival Rate | 2 | 2020 | 12788 | 0.120 |
Why?
|
| Female | 16 | 2023 | 380194 | 0.120 |
Why?
|
| Delivery, Obstetric | 1 | 2021 | 906 | 0.120 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2013 | 30 | 0.120 |
Why?
|
| Alagille Syndrome | 1 | 2013 | 35 | 0.120 |
Why?
|
| Fructose | 1 | 2014 | 288 | 0.110 |
Why?
|
| Bupropion | 1 | 2014 | 303 | 0.110 |
Why?
|
| Benzazepines | 1 | 2014 | 326 | 0.100 |
Why?
|
| Naltrexone | 1 | 2014 | 307 | 0.100 |
Why?
|
| Obesity | 1 | 2014 | 12745 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2021 | 4217 | 0.100 |
Why?
|
| Peripheral Arterial Disease | 1 | 2022 | 1188 | 0.100 |
Why?
|
| Williams Syndrome | 1 | 2013 | 187 | 0.100 |
Why?
|
| Organ Transplantation | 1 | 2021 | 1139 | 0.100 |
Why?
|
| Angioplasty | 1 | 2013 | 364 | 0.090 |
Why?
|
| Inpatients | 1 | 2022 | 2518 | 0.090 |
Why?
|
| United States | 5 | 2023 | 69872 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 1107 | 0.090 |
Why?
|
| Exercise Test | 1 | 2017 | 2074 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 2026 | 0.090 |
Why?
|
| Acute Disease | 1 | 2019 | 7149 | 0.080 |
Why?
|
| Calcium | 1 | 2022 | 5756 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2023 | 57776 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2021 | 3821 | 0.080 |
Why?
|
| Middle Aged | 9 | 2023 | 213383 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2020 | 2942 | 0.080 |
Why?
|
| Critical Care | 1 | 2021 | 2647 | 0.080 |
Why?
|
| Cause of Death | 1 | 2017 | 3584 | 0.070 |
Why?
|
| Phenotype | 1 | 2022 | 16365 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15076 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2022 | 53288 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 5034 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2021 | 1518 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5751 | 0.060 |
Why?
|
| Hypovolemia | 1 | 2023 | 45 | 0.060 |
Why?
|
| Hemodynamics | 1 | 2013 | 4199 | 0.060 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2023 | 149 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2020 | 63114 | 0.050 |
Why?
|
| Time Factors | 2 | 2021 | 40075 | 0.050 |
Why?
|
| Cystatin C | 1 | 2023 | 250 | 0.050 |
Why?
|
| Electrolytes | 1 | 2022 | 282 | 0.050 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2023 | 472 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 8037 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8388 | 0.050 |
Why?
|
| Enalapril | 1 | 2022 | 327 | 0.050 |
Why?
|
| Stroke | 1 | 2022 | 9981 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2021 | 23338 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39050 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2023 | 1155 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 7913 | 0.040 |
Why?
|
| Young Adult | 2 | 2023 | 56430 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2022 | 591 | 0.040 |
Why?
|
| Aftercare | 1 | 2023 | 866 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 214055 | 0.040 |
Why?
|
| Comorbidity | 2 | 2021 | 10388 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2029 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2021 | 1438 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 867 | 0.030 |
Why?
|
| Outpatients | 1 | 2023 | 1486 | 0.030 |
Why?
|
| Death | 1 | 2020 | 678 | 0.030 |
Why?
|
| Thiazoles | 1 | 2022 | 1483 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 1240 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2021 | 1224 | 0.030 |
Why?
|
| Warfarin | 1 | 2022 | 1496 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 1177 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2022 | 1786 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2023 | 2531 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 35136 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 41006 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2021 | 2795 | 0.020 |
Why?
|
| Pyridines | 1 | 2022 | 2825 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2022 | 3461 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3313 | 0.020 |
Why?
|
| Myocardium | 1 | 2023 | 4776 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6489 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3638 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 77449 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8324 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2022 | 6256 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2023 | 6544 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7186 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2023 | 8554 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2022 | 4599 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3952 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 9959 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
| Pregnancy | 1 | 2021 | 29144 | 0.010 |
Why?
|